CORE--BIOTRANSFORMATION AND DISPOSITION

生物转化核心的总体目标是提供一种 毒品和药物领域核心调查人员的互动框架 以增强研究能力为主要重点的异种生物代谢 它的个人调查人员。核心的具体目标是： 1)促进核心调查人员之间的合作研究机会， 2)通过共享提高核心研究人员的研究效率 集体资源和对设施核心功能的访问，以及3) 促进包括分子在内的个人研究计划的发展 毒理学和基于人群的方法。核心将由13个核心组成 代表各部门的调查员(11名常设和2名初级) 环境健康、药物化学、药剂学、医学、医学 华盛顿大学的遗传学和流行病学。艾伦·雷蒂医生 将担任核心的董事。

The overall goal of the Biotransformation Core is to provide an interactive framework to Core investigators working in the area of drug and xenobiotic metabolism with primary emphasis on enhancing research capabilities of its individual investigators. The specific aims of the core are: 1) to foster collaborative research opportunities among Core Investigators, 2) to enhance the research productivity of core investigators via the sharing of collective resources and access to facility core functions, and 3) to facilitate development of individual research programs encompassing molecular toxicology and population-based approaches. The core will consist of 13 core investigators (11 established and 2 junior) representing the Departments of Environmental Health, Medicinal Chemistry, Pharmaceutics, Medicine, Medical Genetics, and Epidemiology of the University of Washington. Dr. Allan Rettie will serve as the director of the Core.